ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 47 filers reported holding ATOSSA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 574 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | – | 574 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | -100.0% | 574 | -99.2% | 0.00% | -100.0% |
| Q4 2022 | $48 | -99.9% | 71,533 | +8.8% | 0.00% | +33.3% |
| Q3 2022 | $48,000 | +41.2% | 65,735 | +23.1% | 0.00% | +50.0% |
| Q2 2022 | $34,000 | 0.0% | 53,400 | -16.2% | 0.00% | 0.0% |
| Q1 2022 | $34,000 | -70.9% | 63,700 | -76.9% | 0.00% | -66.7% |
| Q4 2021 | $117,000 | -54.7% | 275,490 | -45.7% | 0.01% | -50.0% |
| Q3 2021 | $258,000 | -91.6% | 507,700 | -62.4% | 0.01% | -91.5% |
| Q2 2021 | $3,061,000 | +1149.4% | 1,349,779 | +389.0% | 0.14% | +992.3% |
| Q1 2021 | $245,000 | – | 276,028 | +18301.9% | 0.01% | – |
| Q4 2020 | $0 | -100.0% | 1,500 | -89.0% | 0.00% | – |
| Q3 2020 | $1,000 | -88.9% | 13,600 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $9,000 | – | 13,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GSA CAPITAL PARTNERS LLP | 347,392 | $256 | 0.02% |
| XTX Topco Ltd | 167,427 | $123,310 | 0.02% |
| Laurion Capital Management LP | 2,225,800 | $1,639,302 | 0.01% |
| Virtu Financial LLC | 80,728 | $59 | 0.01% |
| Renaissance Technologies | 1,242,370 | $915 | 0.00% |
| LVM CAPITAL MANAGEMENT LTD/MI | 21,000 | $15 | 0.00% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 50,000 | $36,825 | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 133,591 | $98,390 | 0.00% |
| Caption Management, LLC | 75,000 | $55,238 | 0.00% |
| J. L. Bainbridge & Co., Inc. | 11,121 | $8,191 | 0.00% |